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Abstract (1) To study the prevalence and severity of
coronary artery disease (CAD) in diabetic patients. (2) To
provide a detailed characterization of the coronary ath-
erosclerotic burden, including the localization, degree of
stenosis and plaque composition by coronary computed
tomography angiography (CCTA). Single center prospec-
tive registry including a total of 581 consecutive stable
patients (April 2011–March 2012) undergoing CCTA
(Dual-source CT) for the evaluation of suspected CAD
without previous myocardial infarction or revascularization
procedures. Different coronary plaque burden indexes and
plaque type and distribution patterns were compared
between patients with (n = 85) and without diabetes
(n = 496). The prevalence of CAD (any plaque; 74.1 vs.
56 %; p = 0.002) and obstructive CAD (C50 % stenosis;
31.8 vs. 10.3 %; p \ 0.001) were significantly higher in
diabetic patients. The remaining coronary atherosclerotic
burden indexes evaluated (plaque in LM-3v-2v with prox.
LAD; SIS; SSS; CT-LeSc) were also significantly higher in
diabetic patients. In the per segment analysis, diabetics had
a higher percentage of segments with plaque in every
vessel (2.6/13.1/7.5/10.5 % for diabetics vs. 1.4/7.1/3.3/
4.4 % for nondiabetics for LM, LAD, LCx, RCA respec-
tively; p \ 0.001 for all) and of both calcified (19.3 vs.
9.2 %, p \ 0.001) and noncalcified or mixed types (14.4
vs. 7.0 %; p \ 0.001); the ratio of proximal-to-distal rela-
tive plaque distribution (calculated as LM/proximal vs.
mid/distal/branches) was lower for diabetics (0.75 vs. 1.04;
p = 0.009). Diabetes was an independent predictor of
CAD and was also associated with more advanced CAD,
evaluated by indexes of coronary atherosclerotic burden.
Diabetics had a significantly higher prevalence of plaques
in every anatomical subset and for the different plaque
composition. In this report, the relative geographic distri-
bution of the plaques within each subgroup, favored a more
mid-to-distal localization in the diabetic patients.
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Introduction
Patients with diabetes are considered to be at an increased
risk of cardiovascular events and therefore it has been
recommended by many guidelines a more aggressive
management of this subset of patients, especially for those
with established cardiovascular disease [1, 2].
By contrast, on a primary prevention unselected popu-
lation level, some of the preventive measures for diabetic
patients, like the use of antiplatelets, have failed to dem-
onstrate a clear clinical benefit [3] and are no longer rec-
ommended in the absence of clinical evidence of
atherosclerotic disease [4]. The reason for the lack of
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benefit of aspirin in diabetic patients is likely related to the
fact that diabetic patients represents an heterogeneous
subset in what concerns the prevalence and severity of
atherosclerotic coronary burden.
This illustrates the need for risk stratification of diabetic
patients to identify the ones that can benefit from a more
aggressive management at earlier stages. This is an
opportunity for noninvasive imaging modalities, such as
coronary computed tomography angiography (CCTA),
which provides a detailed and comprehensive evaluation of
the presence and extent of coronary artery disease (CAD),
and can play an important role identifying the diabetic
patients that could benefit from a more aggressive pre-
vention of cardiovascular events.
Since CCTA is used mainly as a gatekeeper for the
exclusion of significant CAD [5], most of the referred
patients are at low to intermediate risk, this provides a good
setting to study atherosclerotic disease at an earlier stage.
Therefore the aim of this study is two-folded:
1. To study the prevalence and severity of CAD in
diabetic patients at earlier stages of CAD, to further
evaluate the concept of CAD equivalent.
2. To provide a detailed characterization of the coronary
atherosclerotic burden in diabetic patients, using
the comprehensive information derived from CCTA
on the localization, degree of stenosis and plaque
composition.
Methods
Population
Single center prospective registry, including a total of 772
consecutive patients undergoing CCTA (with Dual source
CT), from April 2011 to March 2012.
Patients were excluded if: (1) previous history of myo-
cardial infarction and/or revascularization procedures
(n = 70); (2) referred for Cardiac CT for other indications
than the evaluation of possible CAD (cardiac CT for atrial
fibrillation ablation or transcatheter aortic valve implanta-
tion procedures; n = 88); (3) referred for suspected acute
coronary syndromes (n = 24); (4) with atrial fibrillation or
other significant arrhythmias during scan acquisition that
compromised image quality (n = 9). This resulted in a
24.7 % of the total population being excluded.
For the purpose of this study, 581 stable patients refer-
red for suspected CAD were included in the context of: (1)
Previous equivocal or inconclusive stress tests or discor-
dant with the clinical evaluation (n = 417, 71.8 %); (2)
Cardiac CT as 1st line investigation of possible CAD
(n = 136, 23.4; %); 3) Preoperative CAD assessment
prior to noncoronary valvular or aortic surgery (n = 17;
2.9 %); (4) Evaluation of possible CAD in cardiomyopa-
thies (Dilated or Hypertrophic) (n = 11; 1.9 %) (Fig. 1:
Patient selection and study design).
The study was approved by the local ethics committee
and all patients gave a written informed consent.
A detailed medical history by means of a risk factors
questionnaire was obtained from the patients to assess for
the presence of: (1) Diabetes mellitus (defined as a fasting
glucose level of ‡7 mmol/l or the need for insulin or oral
hypoglycemic agents) [6]; (2) Dyslipidemia (defined as a
total cholesterol level ‡5 mmol/l or treatment with lipid-
lowering drugs) [7]; (3) Hypertension (defined as blood
pressure ‡140/90 mm Hg or the use of antihypertensive
medication) [8]; (4) Obesity (body mass index ‡30 kg/m2);
(5) positive family history of premature CAD [defined as
the presence of CAD in first-degree relatives younger than
55 (male) or 65 (female) years of age] [9]; (6) smoking
(defined as previous \1 year) or current smoker.
Pre-test probability of CAD was determined using both
the Diamond and Forrester extended CAD consortium
method (DF–CAD consortium model) [10] and the Morise
score [11]. The cardiovascular risk was assessed with the
HeartScore [4]. For the DF–CAD consortium probability
model, as the CAD probability and CV risk of our popu-
lation was shifted to lower probability (less that 2 % had a
‡70 % DF probability), the DF–CAD consortium model
categories ‡30–70 % and ‡70 % were gathered in a
intermediate to high (C30 %) probability group. For the
Morise, the original described cut-off points (for low,
intermediate and high probability) were used, and for the
HeartScore the established high risk cut-off of ‡5 % was
used.
Scan protocol and image reconstruction
All scans were performed with a dual-source scanner
(Somatom Definition, Siemens Medical, Germany), with
the patient in dorsal decubitus and in deep inspiration
breath-hold. Sublingual nitroglycerin was administered to
all patients except when contraindicated and intravenous
metoprolol (5 mg, with a titration dose up to 20 mg) was
administered in patients with heart rate [65 beats/min.
During the scan acquisition, a bolus of iodinated con-
trast (Visipaque, GE Healthcare, USA) was injected at a
6 ml/s infusion rate, followed by a 50-ml saline flush. The
dose of contrast was calculated according to the following
formula: (acquisition time ? 6 s delay) x flow (6 ml/s).
Contrast timing was performed to optimize uniform con-
trast enhancement of the coronary arteries.
Dose reduction strategies—including electrocardio-
gram-gated tube current modulation, reduced tube voltage,
and prospective axial triggering—were used whenever
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feasible. Mean estimated radiation dose was 4.6 ±
3.7 mSv, contrast dose was 98.9 ± 14.4 ml and heart rate
was 65.6 ± 10.6 bpm.
Transaxial images were reconstructed with a temporal
resolution of 83 ms and slice thickness of 0.75 mm with
0.4 mm increments.
Post-processing was carried out using Circulation
software, with multiplanar reconstructions, maximum
intensity projection and volume rendering technique.
Coronary artery analysis
All scans were analyzed in the same session by both a
cardiologist and a radiologist with Level III—equivalent
experience. The Society of Cardiovascular Computed
Tomography (SCCT) recommended classification was used
regarding segmentation (16 segments), stenosis severity
(\25; 25–49; 50–69; 70–99; 100 %) and plaque composi-
tion (calcified, noncalcified, mixed plaque) [12]. In each
coronary artery segment, coronary atherosclerosis was
defined as tissue structures [1 mm2 that existed either
within the coronary artery lumen or adjacent to the coro-
nary artery lumen that could be discriminated from sur-
rounding pericardial tissue, epicardial fat, or the vessel
lumen itself. [13] Coronary atherosclerotic lesions were
quantified for stenosis by visual estimation. Percent
obstruction of coronary artery lumen was based on a
comparison of the luminal diameter of the segment
exhibiting obstruction to the luminal diameter of the most
normal-appearing site immediately proximal to the plaque.
In the detailed per segment analysis, for the distribution
of plaque on the 3 main coronary vessels, this rules were
applied: plaques in the diagonal branches were counted as
belonging to the left anterior descending (LAD); plaques in
the obtuse marginal an intermediate branch were counted
as belonging to the LCx; plaques in the posterior
descending and right postero-lateral were counted as
belonging to the right coronary artery (RCA). For the last
two, coronary dominance was taking into account. The
ratio of ‘‘proximal-to-distal relative plaque distribution’’
was calculated as the proportion of plaques between these
two subgroups: (1) Left main and proximal segments of the
LAD, LCx and RCA; (2) Mid and distal segments of LAD
and RCA, distal LCx and all evaluable coronary branches.
Definition of the coronary atherosclerotic burden
indexes
The following coronary atherosclerotic burden indexes
were evaluated and compared between patients with and
Fig. 1 Patient selection and
study design. CAD coronary
artery disease, TAVI
transcatheter aortic valve
implantation, aFib atrial
fibrillation, MI myocardial
infarction, CABG coronary
artery bypass grafting, PCI
percutaneous coronary
intervention, ACS acute
coronary syndromes
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without diabetes: (1) Coronary artery disease (CAD)—
presence of any plaque in the coronary tree; (2)
‘‘Obstructive CAD’’—presence of at least one plaque with
‡50 % stenosis; (3) ‘‘LM-3v-2v with proximal LAD’’—
Plaque in the left main or in the 3 main epicardial vessels
or in 2 main epicardial vessels including the proximal
left anterior descending (LAD); (4) ‘‘SIS’’—segment
involvement score, obtained as the total number of seg-
ments with plaque; (5) ‘‘SSS’’—segment stenosis score,
obtained by grading the stenosis severity of each segment
with plaque, as was previously described [13]. For these
last two, the prognostically validated cut-offs ([5) were
used [13]
(6) ‘‘Calcium score (CaSc) ‡100’’; (7) ‘‘CaSc ‡75th
percentile’’ (according to published nomograms [14]; (8)
CCTA-adapted Leaman score (CT-LeSc)—this score was
calculated taking in account 3 weighting factors (locali-
zation, plaque composition and stenosis severity) according
to previously described methodology and the same cut-off
for high plaque burden (C8.3) was used (provided as
additional information to the reviewers, since the manu-
script, where it is originally described, is under consider-
ation elsewhere). In Fig. 2, two case examples of diabetic
patients with nonobstructive CAD are shown, with the
different plaque burden indexes.
Statistical analysis
Continuous variables are presented as mean ± SD or
medians (interquartile range) and categorical variables as
frequencies with percentages.
The non-parametric Mann–Whitney or Kruskal–Wallis
tests were used to compare continuous variables. Chi
square test was used to evaluate differences in frequencies.
Differences were regarded significant when p \ 0.05 (two-
tailed).
Multivariate analyses (binary logistic regression
model—enter method) were performed to identify inde-
pendent predictors of CAD (any plaque and obstructive)
using the demographic and clinical variables presented in
Table 1, that were significant in univariate analysis
(p \ 0.05). A second multivariable analyses was per-
formed to identify independent predictors among the clin-
ical scores of CAD probability (Diamond-Forrester CAD
consortium model and Morise score) and the CV risk score
HeartScore. For the detailed per segment analysis, the unit
of measure was each segment and there were no adjust-
ments or corrections made for the serial correlation
between segments.
SPSS version 17.0 (SPSS Inc., Chicago, IL, USA) was
used for all statistical analyses.
Fig. 2 Two case examples of diabetic patients with nonobstructive
CAD. The different plaque burden indexes are shown. CAD coronary
artery disease, SIS segment involvement score, SSS segment stenosis
score, CT-LeSc CT Leaman score, LM left main, LAD left anterior
descending, LCx left circunflex, RCA right coronary artery, LM-3 V-
2VproxLAD plaque in left main or 3 vessels or 2 vessels with
proximal LAD
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Results
Study population
In the final study population (n = 581), 85 patients were
diabetics (14.6 %).
Regarding the demographic and clinical variables, dia-
betic patients were older (mean age 61.4 ± 8.7 vs.
56.9 ± 11.3) and had a higher prevalence of obesity (28.6 %
vs. 17.4 %) and hypertension (84.7 vs. 58.9 %). This was
predominantly a population with low to intermediate CAD
probability, more so in the nondiabetic population since
61.7 % had a DF–CAD consortium\30 and 90.7 % had a
Morise score\16. The cardiovascular risk, as estimated with
the HeartScore (C5 %), was significantly higher in the
patients with diabetes (42.4 vs. 22.6 %) (Table 1).
Independent predictors of CAD
Diabetes was an independent predictor of both the presence
of plaque (OR 1.81; 95 % CI 1.02–3.21; p = 0.041) and of
obstructive CAD (OR 3.69; 95 % CI 2.08–6.53; p \ 0.001).
The other independent predictors of the presence of plaque
were age ‡65 years (OR 3.42; 95 % CI 2.15–5.45;
p \ 0.001), male sex (OR 2.72; 95 % CI 1.85–4.01;
p \ 0.001), hypertension (OR 1.82; 95 % CI 1.23–2.67;
p = 0.002), dyslipidemia (OR 1.89; 95 % CI 1.29–2.77; p =
0.001), chest pain (OR 0.62; 95 % CI 0.42–0.91; p = 0.014)
an DF–CAD consortium ‡30 % (OR 2.62; 95 % CI
1.70–4.05; p \ 0.001), a Morise score ‡16 (OR 2.55; 95 %
CI 1.57–4.14; p \ 0.001), and an HeartScore ‡5 % (OR
3.90; 95 % CI 2.19–6.94; p \ 0.001). The other independent
predictors of obstructive CAD were age ‡65 years (OR 1.98;
95 % CI 1.16–3.37; p = 0.012), male sex (OR 2.94; 95 % CI
1.68–5.15; p \ 0.001), an DF–CAD consortium ‡30 % (OR
1.88; 95 % CI 1.04–3.42; p = 0.038), a Morise score ‡16
(OR 1.84; 95 % CI 1.06–3.20; p = 0.031), and an Heart-
Score ‡5 % (OR 2.71; 95 % CI 1.50–4.88; p = 0.001).
Coronary artery disease prevalence, severity
and coronary atherosclerotic burden indexes—per
patient analysis
The prevalence of plaques in the coronary arteries was high
in the overall study population, but this was significantly
higher for diabetic patients, as almost 3 out of 4 diabetic
patients (74.1 %) had plaques in the coronary arteries.
Table 1 Demographic and clinical characteristics of the study
population
No diabetes
(n = 496)
Diabetes
(n = 85)
p
Demographic
Age 56.9 ± 11.3 61.4 ± 8.7 \0.001
Male sex 277 (55.8) 47 (55.3) 1.000
Risk factors
Obesity (BMI ‡30) 85 (17.4) 24 (28.6) 0.023
Hypertension 292 (58.9) 72 (84.7) \0.001
Dyslipidemia 301 (60.7) 59 (69.4) 0.147
Smoking 118 (23.8) 20 (23.5) 1.000
Family history of premature
CAD
168 (33.9) 26 (30.6) 0.619
Chest pain 265 (54.3) 46 (54.1) 1.000
CAD probability
DF–CAD consortium ‡30 % 189 (38.1) 42 (49.4) 0.049
DF–CAD consortium \30 % 307 (61.9) 43 (50.6)
Morise score ‡16 46 (9.3) 26 (30.6) \0.001
Morise score 9–15 316 (63.7) 53 (62.4)
Morise score 0–8 134 (27.0) 6 (7.1)
CV risk
HeartScore ‡5 % 112 (22.6) 36 (42.4) \0.001
Values are mean ± SD or n (%)
CAD coronary artery disease, BMI body mass index, DF–CAD con-
sortium diamond-forrester CAD consortium model, CV cardiovascular
Table 2 Calcium score and CCTA characteristics of the study
population
No diabetes
(n = 496)
Diabetes
(n = 85)
p
Calcium score
Median 0 (0-67) 68 (0-311) \0.001
CaSc ‡100 96 (19.4) 40 (47.1) \0.001
CaSc ‡75th percentile 60 (12.1) 23 (27.1) 0.001
CCTA
Normal/No plaque 217 (43.8) 22 (25.9) \0.001
Nonobstructive CAD 228 (46.0) 36 (42.4)
Obstructive CAD 51 (10.3) 27 (31.8)
Coronary atherosclerotic burden indexes
Plaque in LM-3v-2v with
prox. LAD
178 (35.9) 53 (62.4) \0.001
Segment involvement score
[5
66 (13.3) 31 (36.5) \0.001
Segment stenosis score [5 25 (5.0) 21 (24.7) \0.001
CT-Leaman Score ‡8.3 79 (15.9) 35 (41.2) \0.001
Technical data
Heart rate (bpm) 65.3 ± 10.6 67.0 ± 10.2 0.172
Contrast dose (ml) 99.3 ± 14.7 96.7 ± 12.3 0.119
Radiation dose (mSv) 4.7 ± 4.9 5.7 ± 3.8 0.069
Values are mean ± SD, median (IQR) or n (%)
CaSc calcium score, CCTA coronary computed tomography angiog-
raphy, CAD coronary artery disease, LM-3v-2v left main, 3 vessel, 2
vessel, LAD left anterior descending, bpm beats per minute, mSv
milisievert
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All the indexes of coronary atherosclerotic burden were
significantly higher in diabetics as compared to nondia-
betics (Table 2; Fig. 3).
For some of these indexes, like the presence of
obstructive disease, and the SSS, the prevalence was 3–5
times higher in diabetics.
By gender, male diabetics had more often coronary
artery disease (any plaque and obstructive), as compared to
their counterparts (Fig. 4).
Prevalence, localization and type of plaques—per
segment analysis
For the analysis of the atherosclerotic burden indexes,
8,136 coronary segments were evaluated for the presence
of plaque, degree of stenosis and type of plaque. Because
of small size (\2 mm) or insufficient image quality related
to artifacts or severe calcification, 866 (10.6 %) segments
were excluded (n = 723–10.4 % in nondiabetics;
n = 143–12.0 % in diabetics).
On a ‘‘per evaluable segment’’ analysis, diabetics had
significantly more segments with plaque and this was
observed in the left main as well as in the other 3 coronary
territories and in both more proximal and more distal
locations (Table 3; Fig. 5). The prevalence of obstructive
plaque was also significantly higher in patients with, as
compared to patients without diabetes (11.6 vs. 6.9 %,
p \ 0.001).
On a ‘‘per segment with plaque’’ analysis, nondiabetics
had an almost equal distribution of plaques between more
proximal (LM/proximal segments) and more mid-to-distal
(Mid/distal/branches) localization (ratio of 1.04), but the
opposite was seen in patients with diabetes, in whom more
plaques were found in the more mid-to-distal segments, as
reflected by a ratio of ‘‘proximal-to-distal relative plaque
distribution’’ of 0.75 (Table 3).
Regarding plaque composition, diabetics had also a
higher percentage of all types of plaques (both calcified and
noncalcified or mixed plaques) per evaluable segment
(Table 4).
Discussion
The main findings of this study are:
1. Although diabetic patients had a higher prevalence of
coronary artery disease, coronary atherosclerotic
plaques were commonly observed in both patients
with and without diabetes.
Fig. 3 Diabetes and indexes of
coronary atherosclerotic burden.
CAD coronary artery disease,
LM left main, LAD left anterior
descending, LCx left circunflex,
LM-3 V-2VproxLAD plaque in
left main or 3 vessels or 2
vessels with proximal LAD, SIS
segment involvement score, SSS
segment stenosis score, CT-
LeSc CT Leaman score
Fig. 4 Prevalence of coronary artery disease (any plaque and
obstructive) across the different diabetes and sex subgroups. CAD
coronary artery disease
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2. Several different coronary atherosclerotic burden indexes
were more prevalent in diabetics, indicating more diffuse
and severe CAD, and this was especially true for males.
3. In the detailed per segment analysis, diabetics had a
higher percentage of segments with plaque in every
vessel and of both calcified and noncalcified or mixed
types; ratio of proximal-to-distal relative plaque distri-
bution suggested an anatomical gradient in the geo-
graphic distribution, with higher proportion of disease
involvement in the mid/distal/branches segments in
diabetic patients.
Diabetes as an heterogeneous group—not all diabetics
have the same CV risk
For many years, diabetic patients have been considered as a
subset at higher risk of cardiovascular events. Nevertheless,
Table 3 Prevalence, and localization of plaques—per segment analysis
No diabetes (n = 496;
6,957 segments)
Diabetes (n = 85;
1,187 segments)
p
All evaluable segments 6,234 (89.6) 1,044 (88.0) 0.093
Segments with any plaque 1,008 (16.2) 352 (33.7) \0.001
Coronary artery distribution
Any plaque in the LM 87 (1.4) 27 (2.6) 0.007
Any plaque in the RCA 276 (4.4) 110 (10.5) \0.001
Any plaque in the LAD 441 (7.1) 137 (13.1) \0.001
Any plaque in the LCx/Ramus 204 (3.3) 78 (7.5) \0.001
Proximal versus distal distribution
Any plaque in LM/Proximal 514 (8.2) 151 (14.5) \0.001
Any plaque in Mid/Distal/Branches 494 (7.9) 201 (19.3) \0.001
‘‘Ratio of proximal-to-distal relative plaque distribution’’ 1.04 (514/494) 0.75 (151/201) 0.009
‘‘Ratio of proximal-to-distal relative plaque distribution’’—proportion of plaques in the ‘‘LM/Proximal’’ versus ‘‘Mid/Distal/branches’’
LM left main, RCA right coronary artery, LAD left anterior descending, LCx left circunflex, Ramus intermediate branch, ‘‘LM/Prox’’ left main or
proximal segments of the LAD, LCx or RCA, ‘‘Mid/Distal/Branches’’ mid or distal segments of the LAD and RCA, distal segment of the LCx,
and branches
Fig. 5 Prevalence and localization of plaques (any plaque) on a per
segment analysis. LM left main, LAD left anterior descending, LCx
left circunflex, RCA right coronary artery
Table 4 Type of plaques—per
segment analysis
LM left main, RCA right
coronary artery, LAD left
anterior descending, LCx left
circunflex, Ramus intermediate
branch, ‘‘LM/Proximal’’ left
main or proximal segments of
the LAD, LCx or RCA, ‘‘Mid/
Distal/Branches’’ Mid or distal
segments of the LAD and RCA,
distal segment of the LCx, and
branches
No diabetes (n = 496;
6,957 segments)
Diabetes (n = 85;
1,187 segments)
p
All evaluable segments 6,234 (89.6) 1,044 (88.0) 0.093
Segments with any plaque 1,008 (16.2) 352 (33.7) \0.001
Calcified plaque
All segments 571 (9.2) 202 (19.3) \0.001
LM/Proximal 291 (4.7) 83 (8.0) \0.001
Mid/Distal/Branches 280 (4.5) 119 (11.4) \0.001
Noncalcified or mixed plaques
All segments 437 (7.0) 150 (14.4) \0.001
LM/Proximal 223 (3.6) 68 (6.5) \0.001
Mid/Distal/Branches 214 (3.4) 82 (7.9) \0.001
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it has been difficult to prove a clear benefit of some primary
prevention measures, like is the case of aspirin in the pri-
mary prevention of cardiovascular events. This inconsistent
benefit of aspirin in the absence of clinical manifestations
of cardiovascular disease, can be related to the fact that it is
less effective in these patients [15] or more likely that
diabetic patients are an heterogeneous group in terms of
cardiovascular disease presence and extent. This way,
without risk stratification, we could be overtreating some
low risk diabetic patients, exposing them to the risk of side
effects that could offset the reduction in expected athero-
thrombotic events rate.
Of note, there has been a more consistent beneficial
effect of aspirin as primary preventive measure in males,
for reducing the risk of myocardial infarction [3] and this is
in line with our findings of higher prevalence of coronary
plaques and obstructive CAD in this subgroup, as com-
pared to females.
Recently, Saely et al. [16] revisited the concept of dia-
betes as a CAD equivalent in a study comparing the vas-
cular event rate of patients according to the presence of
diabetes and/or CAD. In this study, diabetes was not per se
a CAD risk equivalent, since diabetic patients without
significant CAD had a lower event rate than nondiabetic
patients with significant CAD.
CCTA derived coronary atherosclerotic burden indexes
Scores derived from invasive angiography have previously
demonstrated to further stratify diabetic patients with more
advanced CAD [17]. We hypothesized that this could also be
the case for diabetics with less severe CAD, using the com-
prehensive information derived from CCTA on the presence,
localization, degree of stenosis and plaque composition.
Several different aspects of coronary disease are
reflected in these scores: prevalence and severity (any
plaque and obstructive CAD), number of plaques (SIS),
number and distribution (plaque in LM-3v-2v with prox.
LAD), number and stenosis severity (SSS), absolute and
relative amount of calcified plaque (CaSc ‡100 and ‡75th
percentile) and localization, stenosis severity and type of
plaque (CT-Le score). All the coronary atherosclerotic
burden indexes were significantly higher in diabetics as
compared to nondiabetics, reflecting the higher prevalence
as well as the more severe coronary disease of this subset
of patients and they can be useful as noninvasive imaging
tools for risk stratification. Some of these indexes have
already been prognostically validated and demonstrated a
good correlation with major cardiovascular events [13, 18,
19]. In our view, since the prevalence of plaque is very
high, even in this predominantly low-to-intermediate CAD
probability population, these coronary atherosclerotic bur-
den indexes can help risk stratify patients and should
ideally be included in the CCTA report. However, since
they convey information on different aspects of CAD, with
some overlap in the information they provide and, in
clinical practice, reporting on all of them is not suitable,
ideally we should be able to decide in the future which
one(s) should be routinely used, based on their prognostic
performance.
Anatomical distribution and plaque composition
In this report, the higher prevalence of plaques in diabetic
patients was seen in the left main as well as in the other 3
coronary territories and in both proximal and distal locations.
Regarding the left main and the other proximal locations, we
observed a higher percentage of plaques in diabetics as
compared to nondiabetics. This is in line with previous
studies linking the geographic distribution of myocardial
infarction culprit lesions to more proximal locations in the
coronary tree [20] and could explain the higher incidence of
coronary events experienced by diabetic patients.
One interesting finding in our study is related to the
relative geographic localization of plaques in diabetics as
compared to patients without diabetes.
Although in prevalence of evaluable segments, diabetics
had more plaques in every location (both proximal and dis-
tal) compared to nondiabetics, the relative geographic plaque
distribution was different in the two subgroups of patients,
since diabetics had a ratio of ‘‘proximal-to-distal relative
plaque distribution’’ of 0.75 (vs. 1.04 for nondiabetics),
suggesting a higher predisposition to disease involvement of
the more distal segments. This finding, on a per segment
analysis, together with the higher prevalence of a SIS[5 on
the per patient analysis reflects the more diffuse nature of
coronary atherosclerotic burden of diabetic patients.
As diabetic patients are considered to be a model of
more advanced CAD, this could suggest that as the coro-
nary atherosclerosis progresses, distal segments become
more involved by disease, although serial measurements in
time would be the ideal setting to evaluate this hypothesis.
The per segment analysis allowed also the evaluation of
the plaque composition. Diabetic patients had a signifi-
cantly higher prevalence of segments with both calcified
and noncalcified or mixed plaques, in both more proximal
or more distal locations. The proportion of calcified to
noncalcified or mixed plaques was the same for both sub-
groups of patients.
Limitations
There are a number of limitations related to this report:
1. This is a single center data with medium size cohort;
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2. The population included in our study was mainly
composed of patients with low to intermediate CAD
probability and CV risk, as this reflects daily practice
of CCTA being used as a gatekeeper to exclude
obstructive CAD and are in line with the recommen-
dations. Since coronary plaques were present in nearly
60 % of the patients, this was an opportunity to
evaluate the coronary atherosclerotic burden pattern of
DM patients at earlier stages.
3. There were some differences in the baseline charac-
teristics of the two subgroups of patients, that could
have contributed to the higher disease extent observed
in diabetic patients. Nevertheless, after adjusting for
those differences, diabetes remained an independent
predictor of both the presence and severity of CAD.
4. Since patients were referred for CCTA because of
symptoms and/or the results of stress tests, some
referral bias has to be acknowledged.
Conclusions
Diabetes was an independent predictor of CAD and was
also associated with more advanced CAD, evaluated by
indexes of coronary atherosclerotic burden.
The comprehensive information regarding the presence,
severity and type of plaque noninvasively provided by
CCTA, has made possible a detailed characterization of the
coronary disease pattern of diabetic patients at an earlier
stage of disease.
Diabetics had a significantly higher prevalence of pla-
ques in every anatomical subset (type of vessel and both
proximal or distal localizations) and for the different pla-
que composition (both calcified and noncalcified or mixed).
In this report, the relative geographic distribution of the
plaques within each subgroup, favored a more mid-to-distal
localization in the diabetic patients.
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